Hemodialysis

Humacyte First Quarter 2023 Financial Results and Business Update

Retrieved on: 
Friday, May 12, 2023
Infection, JDRF, Kidney disease, Biologics license application, Surgeon, File, Conference call, AC 25.1309-1, Aneurysm, Survival, Research, Trauma center, Sale, Dialysis, Regenerative medicine, Incidence, Polytetrafluoroethylene, Ischemia, Journal, Publication, Patient, Investment, Level, HUMA, Host, Hemodialysis, BVP, FDA, HAV, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, BLA, Conference, Food, Safety, Fistula, Pharmaceutical industry, Hospital, Video game, Trauma

DURHAM, N.C., May 12, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced financial results for the first quarter ended March 31, 2023, and highlighted recent corporate accomplishments.

Key Points: 
  • ET today -
    DURHAM, N.C., May 12, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced financial results for the first quarter ended March 31, 2023, and highlighted recent corporate accomplishments.
  • There was no revenue for the first quarter of 2023, compared to $0.2 million for the first quarter of 2022.
  • Research and development expenses were $17.3 million for the first quarter of 2023, compared to $16.3 million for the first quarter of 2022.
  • Net cash used in operations was $18.6 million for the first quarter of 2023 compared to $18.8 million for the first quarter of 2022.

Global Blood Purification Devices Market Report 2023: Developments in the Absorption, Filtration, and Dialysis Processes Fuel Expansion - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 11, 2023
Surgery, Health, Medical Devices, Hospital, Blood, Hypertension, Location, Porter's five forces analysis, Absorption, Kidney failure, Dialysis, Asahi Kasei, Competition, Baxter International, Adsorption, Continuity, Cytosorbents Corporation, Growth, Kidney, Diabetes, SWOT, Filtration, Fresenius, Incidence, USD, D, COVID-19, Pharmaceutical industry, Medical device, Hemoperfusion, Haemonetics, Hemodialysis, Application

The Global Blood Purification Devices Market was valued at USD 13.65 billion in the year 2021.

Key Points: 
  • The Global Blood Purification Devices Market was valued at USD 13.65 billion in the year 2021.
  • Americas region is estimated to hold the maximum share in global Blood Purification Devices followed by Europe & APAC.
  • The report analyses the Blood Purification Devices Market by Application - (Continuous Blood Purification, Hemodialysis, Hemoperfusion).
  • The report analyses the Blood Purification Devices Market by End Users - (Hospitals & Clinics, Dialysis Centres, Others).

Global Hemodialysis Market Report 2022 to 2030 - Increasing Number of ESRD Patients is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022
Medical Supplies, Medical Devices, Health, Diabetes, Managed Care, Biotechnology, PMP, Dialysis, Person, Hemodialysis, Government, International Diabetes Federation, ESRD, Kidney failure, Patient, Prevalence, Arteriovenous fistula, Chronic kidney disease, CKD, Incidence, Indian government response to the COVID-19 pandemic, Diabetes, COVID-19, Kidney, Hypertension, Fistula, IDF, USD, Medical device, Pharmaceutical industry

The global Hemodialysis market size is expected to reach USD 136.86 billion by 2030, according to a new study.

Key Points: 
  • The global Hemodialysis market size is expected to reach USD 136.86 billion by 2030, according to a new study.
  • The report gives a detailed insight into the current market dynamics and provides analysis on future market growth.
  • Renal failure and chronic kidney disease are becoming more common, which is one of the main drivers of market expansion.
  • Therefore, increasing ESRD prevalence is increasing the financial burden of kidney disorders globally and is a major driver of rising service revenue.

Augmedix Announces Partnership with Veterinary Specialty Center to Support Emergency Veterinary and Specialty Care

Retrieved on: 
Wednesday, November 16, 2022
SAN, EHR, VSC, Veterinarian, Radiation therapy, Trauma, Hospital, Trial balance, Life, Partnership, Health, Patient, Fatigue, Rehabilitation, Telehealth, Nephrology, Internal medicine, Natural language processing, Veterinary specialties, Neurology, Animal, Form 10-K, Critical care, Pain management, Medicine, Veterinary medicine, Medical device, Neurosurgery, Anesthesia, Dermatology, Radiology, Hemodialysis

With the implementation of Augmedix solutions this year, Veterinary Specialty Center has the ability to alleviate administrative burden and increase productivity.

Key Points: 
  • With the implementation of Augmedix solutions this year, Veterinary Specialty Center has the ability to alleviate administrative burden and increase productivity.
  • This has resulted in increased patient volumes and the capacity for Veterinary Specialty Center to take on more emergency cases.
  • With Augmedix, we are able to focus on patient care and accommodate more clients, said Dr. Jennifer Herring, MS, DACVECC, of Veterinary Specialty Center.
  • This partnership with Augmedix has made everyones lives so much easier, added Dr. Margaret Foley, CHPV, of Veterinary Specialty Center.

Flow Cytometry Market To Reach A Revised Size of USD 8.4 Billion By 2028, Growing At A CAGR of 8.7% | Valuates Reports

Retrieved on: 
Wednesday, October 12, 2022
Therapy, Nutrition analysis, Review, Peritoneal dialysis, CAGR, QPCR, The Comment Section, Comment, Hemodialysis, DPCR, Optometry, Fiducial, Digital, Device file, USD, Fiducial marker, Flow cytometry, Video game, Telecommunication, Cryptocurrency, Pet, Responsive neurostimulation device

- Global Flow Cytometry Reagents Market Insights, Forecast to 2028

Key Points: 
  • - Global Flow Cytometry Reagents Market Insights, Forecast to 2028
    - The global digital polymerase chain reaction market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
  • - The global Hip Replacement market size is projected to reach USD 2688.1 million by 2028, from USD 2257.7 million in 2021, at a CAGR of 2.5% during 2022-2028.
  • - The global Orthopedic Devices market size is projected to reach USD 43250 million by 2027, from USD 34190 million in 2020, at a CAGR of 3.0% during 2021-2027.
  • - The global Biometrics market size is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.

End Stage Renal Disease Global Market Report 2022: Value to Reach $18.06 Billion by 2027 at a CAGR of 16.63% - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 7, 2022
Health, Infectious Diseases, Acquisition, Decision-making, USD, Treatment, Research, Strategic management, Peritoneal dialysis, Market share analysis, User (computing), Business Growth Fund, Value, Dialysis, Customer support, COVID-19, Growth, Collaborative partnership, Transplant, Investment, CAGR, Weakness, Hospital, Kidney, Diagnosis, Use, End Stage Renal Disease Program, Clifton Springs Hospital & Clinic, Royal Belfast Academical Institution, News, Compound annual growth rate, Kidney bean, State, Gaps, Mergers and acquisitions, Medical device, Retail, Blood, Hemodialysis

The "End Stage Renal Disease Market Research Report by Treatment (Dialysis and Transplantation), Diagnosis, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "End Stage Renal Disease Market Research Report by Treatment (Dialysis and Transplantation), Diagnosis, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The United States End Stage Renal Disease Market size was estimated at USD 7,173.99 million in 2021, USD 8,638.02 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.63% to reach USD 18,063.62 million by 2027.
  • This research report categorizes the End Stage Renal Disease to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Treatment, the market was studied across Dialysis and Transplantation.
  • Based on Diagnosis, the market was studied across Blood tests, Imaging tests, Kidney sample removal for testing, and Urine tests.

First Patient Enrolled in Merit Medical’s WRAPSODY™ Registry (WRAP) Study

Retrieved on: 
Tuesday, July 5, 2022
WRAP, Critical care, Patient, AVF, Arteriovenous fistula, CEO, PTFE, Dialysis, GLOBE, Endoscopy, Adapter, Sale, Hemodialysis, MMSI, CE marking, Blood, AVG, Stenosis, Cardiology, NASDAQ, Radiology, Hospital, Pharmaceutical industry, Medical device, Medicine

The WRAPSODY Cell-Impermeable Endoprosthesis was created to help overcome this challenge by maintaining the integrity of the dialysis outflow circuit.

Key Points: 
  • The WRAPSODY Cell-Impermeable Endoprosthesis was created to help overcome this challenge by maintaining the integrity of the dialysis outflow circuit.
  • Dr. Dean Huang, consultant diagnostic and interventional radiologist at Kings College Hospital in London, England, enrolled the first patient in the WRAP Registry.
  • The patients being treated with the WRAPSODY Cell-Impermeable Endoprosthesis have historically had few clinical options, Dr. Huang said.
  • The WRAP study will add to the growing body of evidence on WRAPSODYs ability to achieve durable outcomes for this vulnerable patient population.

Asia Pacific Blood Purification Equipment Market 2021-2031: Industry to Grow by 6.3% CAGR - ResearchAndMarkets.com

Retrieved on: 
Monday, July 4, 2022
Medical Devices, Health, CRRT, Prevalence, COVID-19, Hemodialysis, Adoption, Health, Asia-Pacific, Pharmaceutical industry, Hemoperfusion

The "Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
  • Asia Pacific blood purification equipment market will grow by 6.3% annually with a total addressable market cap of $72.37 billion over 2022-2031 owing to the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
  • In-depth qualitative analyses include identification and investigation of the following aspects:

The Worldwide Dialysis Industry is Predicted to Reach $145.8 Billion by 2030 at a 3.6% CAGR from 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 13, 2022
Managed Care, Health, Medical Supplies, Diabetes, Blood, National Kidney Foundation, ESRD, Peritoneal dialysis, Peritoneum, Chronic kidney disease, Patient, Kidney failure, Dialysis, USD, Abdomen, Salt, Product, Economic development, Hemodialysis, Renal replacement therapy, CAGR, Growth, Prevalence, Water, Developing country, Medical device, Pharmaceutical industry

The Global Dialysis Market size was valued to USD 105.58 billion in 2021, and is predicted to garner USD 145.85 billion by 2030, with a CAGR of 3.6% from 2022-2030.

Key Points: 
  • The Global Dialysis Market size was valued to USD 105.58 billion in 2021, and is predicted to garner USD 145.85 billion by 2030, with a CAGR of 3.6% from 2022-2030.
  • Hemodialysis includes extra-corporeal purification of blood, whereas Peritoneal Dialysis includes blood purification by using peritoneum in the patient's abdomen for dialysis.
  • This scenario has increased the penetration of dialysis treatment over the years, thereby supplementing the growth of the global dialysis market.
  • However, risks & complications associated with dialysis, and product recall may limit the growth of the dialysis market.

The $5.1B Blood Purification Equipment Market in North America, 2021-2031 - Rising Adoption of Home-based Healthcare, and Rising Health Consciousness Amid COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 21, 2022
Medical Devices, Health, Health, Table, Adoption, CRRT, COVID-19, Research, Hemodialysis, Prevalence, Pharmaceutical industry, Hemoperfusion

The "North America Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "North America Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
  • North America's blood purification equipment market is projected to grow by 5.6% annually in the forecast period and reach $5,100.8 million by 2031, driven by the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic.
  • Highlighted with 22 tables and 40 figures, this 92-page report is based on a comprehensive research of the entire North America blood purification equipment market and all its sub-segments through extensively detailed classifications.
  • The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.